RUSSO, PIERLUIGI
RUSSO, PIERLUIGI
SCIENZE BIOMEDICHE E BIOTECNOLOGICHE
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)
2020-01-01 Breccia, Massimo; Olimpieri, Pier Paolo; Olimpieri, Odoardo; Pane, Fabrizio; Iurlo, Alessandra; Foggi, Paolo; Cirilli, Alessia; Colatrella, Antonietta; Cuomo, Marcello; Gozzo, Lucia; Summa, Valentina; Corradini, Paolo; Russo, Pierluigi
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA)
2021-01-01 Breccia, Massimo; Celant, Simone; Olimpieri, Pier Paolo; Olimpieri, Odoardo M; Pane, Fabrizio; Iurlo, Alessandra; Cirilli, Alessia; Colatrella, Antonietta; Gozzo, Lucia; Pugliese, Sara; Summa, Valentina; Foggi, Paolo; Corradini, Paolo; Russo, Pierluigi
The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real‐world study on AIFA monitoring registries
file da validare2024-01-01 Breccia, Massimo; Celant, Simone; Palandri, Francesca; Passamonti, Francesco; Olimpieri, Pier Paolo; Summa, Valentina; Guarcello, Annalisa; Palumbo, Giuseppe Alberto; Pane, Fabrizio; Guglielmelli, Paola; Corradini, Paolo; Russo, Pierluigi
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA) | 1-gen-2020 | Breccia, Massimo; Olimpieri, Pier Paolo; Olimpieri, Odoardo; Pane, Fabrizio; Iurlo, Alessandra; Foggi, Paolo; Cirilli, Alessia; Colatrella, Antonietta; Cuomo, Marcello; Gozzo, Lucia; Summa, Valentina; Corradini, Paolo; Russo, Pierluigi | |
| Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA) | 1-gen-2021 | Breccia, Massimo; Celant, Simone; Olimpieri, Pier Paolo; Olimpieri, Odoardo M; Pane, Fabrizio; Iurlo, Alessandra; Cirilli, Alessia; Colatrella, Antonietta; Gozzo, Lucia; Pugliese, Sara; Summa, Valentina; Foggi, Paolo; Corradini, Paolo; Russo, Pierluigi | |
| The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real‐world study on AIFA monitoring registries | 1-gen-2024 | Breccia, Massimo; Celant, Simone; Palandri, Francesca; Passamonti, Francesco; Olimpieri, Pier Paolo; Summa, Valentina; Guarcello, Annalisa; Palumbo, Giuseppe Alberto; Pane, Fabrizio; Guglielmelli, Paola; Corradini, Paolo; Russo, Pierluigi | file da validare |